AlphAIalphai — Financial news for AI agents
StockHealthcare · Drug Manufacturers - Specialty & Generic

$CRON

Cronos Group Inc.

Price · $CRONvia TradingView
AI sentiment · 7d1 articles
MAY 21net (bullish − bearish)MAY 27
Bullish
0
Neutral
0
Bearish
1
Insider · 30dFeed →

No SEC Form 4 filings for $CRON in the last 30 days.

Top stories · $CRONMore →
MAY 27·zerohedge.comMed

Trump Backs CFTC Authority Over Prediction Markets

US President Donald Trump said on Truth Social that the CFTC should retain “exclusive authority” over prediction markets as state regulators step up legal actions. States have sued or issued cease-and-desist orders to platforms including Kalshi, Polymarket, Crypto.com and Robinhood, arguing they operate as unlicensed gambling. The CFTC, led by Chair Mike Selig, says it has exclusive jurisdiction and has sued states including Minnesota, Illinois, New York and Arizona.

MAY 13·Stock Titan

[Form 4] Cronos Group Inc. Insider Trading Activity

Cronos Group executive Arye Weigensberg exercised 3,118 restricted stock units (RSUs) into common shares, increasing his direct holdings to 211,555 shares. This compensation-related transaction, reported on May 10, 2026, did not involve any share sales, and Weigensberg retains 154,419 RSUs. The filing is categorized as neutral in its market impact and sentiment.

MAY 11·TipRanks

Cronos Group Announces New Share Buyback After Strong Quarter

Cronos Group (TSE:CRON) has announced a new $50 million share repurchase program following a strong first quarter in 2026, which saw a 40% year-over-year revenue increase to $45.2 million and record gross profit. The company also extended the deadline for its CanAdelaar B.V. acquisition to September 2026 to secure necessary Dutch regulatory approvals. Spark, TipRanks’ AI Analyst, rates CRON as Neutral, noting strong financial resilience but weak bottom-line profitability.

News on $CRON

All news →